The next big think: Artificial intelligence arrives at Penn Gastroenterology (Penn Medicine) 

Penn Gastroenterology has begun using GI Genius™, the first FDA-approved AI device for colonoscopy, to boost real-time detection of precancerous polyps—particularly in underserved communities in West Philadelphia. Backed by a grant, the program aims to lower colon cancer risk by improving adenoma detection rates (ADR), where Penn already surpasses the national benchmark (38% vs. 26%). Early results show GI Genius™ improves pathology-confirmed findings by 13% over standard colonoscopy. While cost and reimbursement remain challenges, Penn is piloting the technology at no charge to patients, positioning AI as a potential future standard of care in colon cancer prevention.